We have used cultured PC1 2 cells and rat sympathetic neurons as model systems to examine the regulation of neuronal cell death and survival. Because nitric oxide (NO) may be involved in nerve growth factor (NGF) signaling in PC12 cells, we tested NO-generating compounds for their ability to protect PC12 cells and sympathetic neurons from death after withdrawal of trophic support. Three such agents, S-nitroso-Nacetylpenicillamine (SNAP), diethylenetriamine NO adduct (DETA-NO), and sodium nitroprusside provide (SNP), were found to promote complete short-term survival after removal of serum from naive PC12 cells and of NGF from neuronally differentiated PC12 cells and sympathetic neurons. One major target of NO action is guanylate cyclase, which is activated by nitrosylation of its heme prosthetic group. We observed that inhibition of guanylate cyclase blocks the protective effects of the NO generators on trophic factor-deprived PC12 cells and sympathetic neurons without preventing NGF-induced survival. We also found that permeant cGMP analogs and an inhibitor of cGMP-specific phosphodiesterase enhance cell survival, suggesting that the protective effects of NO are mediated by activation of guanylate cyclase and increased intracellular cGMP. N-Nitro-L-arginine methyl ester, a NO synthase inhibitor, did not block NGF-promoted PC12 cell or sympathetic neuron survival. These findings indicate that like NGF, NO has survivalpromoting actions on neurons but that the two agents work by initially independent mechanisms.
Much recent evidence implicates nitric oxide (NO) as a major synaptic signaling agent in the nervous system (Bredt and Snyder, 1992; Snyder, 1992) . Apart from this role under physiological conditions, NO appears to mediate neuronal death when produced in excess. For instance, during cerebral ischemia, excessive glutamate release leads to overstimulation of NMDA receptors which in turn causes Ca2+ influx and activation of the Ca'+-dependent form of NO synthase (NOS) (Garthwaite, 1991) . Because inhibitors of NOS reduce the extent of brain damage caused by experimentally induced cerebral &hernia, NO appears to be intimately involved in the death process (Nowicki et al., 1991) . This is further supported by observations that NOS inhibitors as well as other agents that reduce NO levels protect cultured neurons from glutamate toxicity (Dawson et al., 1991 (Dawson et al., , 1993 . The mechanism by which excessive NO leads to neuronal cell death is unclear but could include direct activation or inhibition of signaling or metabolic pathways (Stamler, 1994; Zhang et al., 1994) or reaction with superoxide to form the highly reactive peroxynitritc anion (Beckman et al., 1990; Lipton, 1993; Estevez et al., 1995; Mitrovec et al., 1995; Troy et al., 1996) . NO has also been reported to be cytoprotective in certain circumstances. For instance, NO donors and the NO precursor, L-argininc, are cardioprotcctive in models of myocardial ischemia-reperfusion (Johnson et al., 1991; Morikawa et al., 1992; Siegfried et al., 1992) . Very recent studies have revealed that NO inhibits apoptosis of human B lymphocytes caused by EpsteinBarr virus reactivation (Mannick et al., 1994) and antigen presentation (Genaro et al., 1995) as well as the death of cytokinedeprived human eosinophils (Beauvais et al., 1995) .
The effects of NO with regard to cytoprotection have led us to examine its actions on several well characterized neuronal models in which cell death is initiated by withdrawal of trophic support. One of these consists of primary cultures of rodent sympathetic neurons, which are dependent on nerve growth factor (NGF) for support and which undergo apoptotic death after NGF withdrawal (Edwards et al., 1991; Batistatou and Greene, 1993) . The other system is represented by the PC12 rat pheochromocytoma cell line. In serumcontaining medium, PC12 cells replicate and display many characteristics of pheochromoblasts, the precursors of chromaffin cells and sympathetic neurons (Greene and Tischler, 1976) . Within several days of exposure to NGF, these cells stop dividing and undergo neuronal differentiation. When cultured in serum-free medium without NGF or other growth factors, both pheochromoblast-like and neuronally differentiated (NGF-pretreated) PC12 cells die by an apoptotic mechanism. However, addition of NGF to the serum-free medium rescues the cells from death. Thus, in serum-free conditions, PC12 cells resemble sympathetic neurons in the requirement for NGF (Greene, 197X; Batistatou and Greene, 1991; Rukenstein et al., 1991) .
We and others have proposed that withdrawal of trophic support causes neuronal cells to die because they inappropriately attempt either to traverse the cell cycle (if in a proliferative stage) or (if postmitotic) to reenter the cell cycle (Batistatou and Greene, 1993; Rubin et al., 1993; Ferrari and Greene, 1994) . In support of this hypothesis, we have reported that inhibition of PC12 cell proliferative potential by expression of a dominantnegative form of Ras or that exposure of PC12 cells and sympathetic neurons to a variety of cell cycle blockers rescues them from apoptotic death caused by loss of trophic support (Ferrari and Greene, 1994; Ferrari et al., 1995; Yan et al., 1995; Farinelli and Greene, 1996; Park et al., in press) . It was reported recently that PC12 cells express a constitutively active form of NOS and that this is upregulated after NGF treatment. Moreover, evidence was presented which indicated that NGF-induced NO synthesis serves to initiate cessation of proliferation in this cell line (Peunova and Enikolopov, 1995) . NO has previously been shown to be cytostatic for a variety of cell types, possibly through a mechanism involving inhibition of ribonucleotide reductase (Struehr and Nathan, 1989; Garg and Hassid, 1990; Lepoivre et al., 1990; Kwon et al., 1991) . These observations led us to the initial expectation that provision of extrinsic NO would prevent neuronal cells from attempting to either traverse or reenter the cell cycle and might thereby protect them from death triggered by withdrawal of trophic support. They also raised the question of whether enhancement of NO generation might account for NGF-promoted survival.
We report here that NO generators significantly retard the death of PC12 cells and sympathetic neurons after withdrawal of serum and/or NGF. However, our findings suggest that the mechanism of this effect is not dependent on inhibition of cellular proliferation, but rather on the activation of guanylate cyclase and generation of intracellular cGMP. Finally, our observations indicate that promotion of survival by NGF does not require generation of NO.
MATERIALS AND METHODS
PC12 cell culture. PC12 cell cultures (passage 26-34) were maintained as described previously (Greene and Tischler, 1976; in RPM1 1640 medium supplemented with 10% horse strum and 5% fetal bovine serum (15% serum, complete medium) and seeded on collagencoated plastic cell culture dishes (Falcon, Becton Dickinson, Lincoln Park, NJ) . For the studies involving neuronally differentiated PC12 cells, naive cells were washed free of serum by three cycles of centrifugationi resuspension in RPM1 1640 medium. The cells were then replated onto 150 mm collagen-coated plastic dishes in the presence of 100 @ml NGF and harvested for survival studies lo-14 d later.
Assay for PC12 cell survival in serum-free or NGF-free conditions. Cell survival was assayed as previously described (Batistatou and Greene, 1991; Rukenstein et al., 1991) . Cells were washed extensively with serumfree RPM1 1640 medium (5 times on the dish followed by 5 cycles of centrifugationiresuspension) and replated into collagen-coated 24.well tissue culture dishes at a density of 2 X IO5 cells/well in a volume of 1 ml. In these studies, all pharmacological agents tested for their effects on survival were added at the time of plating, because it had been experimentally determined that a pretreatment period was not necessary. For determination of cell viability, cells were lysed and intact nuclei were counted using a hemacytometer (Soto and Sonnenschein, 1985) at daily intervals. In this assay, nuclei of dead cells generally disintegrate or, if in the process of apoptosis, appear pyknotic and irregularly shaped. In contrast, nuclei of living cells arc phase bright and have clearly defined limiting membranes. Cell counts were performed on triplicate wells. The data are expressed as a percentage of the cell number initially plated.
/-7H]thymidine incorporation. Assay of thymidine incorporation was conducted as described previously . PC12 cells were plated in collagen-coated 24-well plates at a density of 4 X IO5 cells/well in RPM1 1640 serum-free medium containing 3 pM insulin (Sigma, St. Louis, MO). Immediately after plating, cultures were treated with the indicated NO generator at various concentrations and for 18 hr befpre exposure to a 1 hr pulse of [3H]thymidine (1 $Zi/ml).
Culture and survival assay of sympathetic neurons. Primary cultures of sympathetic neurons were prepared from the dissociated superior cervical ganglia of postnatal day 2 rats (Lee et al., 1980) . Cells were plated at a density of 0.5 ganglia/well in 24.well collagen-coated plastic dishes. Cultures were grown in RPM1 1640 medium containing 10% heatinactivated horse serum and 100 rig/ml mouse NGF. One day after plating, uridine and 5-fluorodeoxyuridine (10 FM each) were added to the cultures and left for 2 d to eliminate non-neuronal cells. On the third day after plating, NGF was removed by washing the cultures three times with RPM1 1640 medium containing 10% horse serum, followed by the addition of 0.5 ml of the same medium containing antibody against mouse NGF (1:200 dilution, Sigma) and the indicated pharmacological agent(s). Toxicity of the NO generators was assessed by adding back 100 rig/ml NGF in replicate cultures after the initial NGF washout. Viability of the neurons was assessed by counting the number of intact, phase-bright neurons in each well by the method of strip counting (Greene et al., 1978; Rydel and Greene, 1988; Farinelli and Greene, 1996) . This determination was made on the initial day of NGF withdrawal and then on subsequent days. Results are expressed as the percentage of viable neurons relative to that present initially after NGF withdrawal.
RESULTS

NO generators suppress the death of serum-deprived PC12 cells
To examine the effects of NO on neuronal cell death, we first used serum-deprived cultures of PC12 cells. In this model, typically 60-75% of the cells die after 1 d of serum withdrawal, and virtually all die by 3-4 d. Addition of NGF or a variety of other agents blocks this death (Rukenstein et al., 1991) . As shown by the dose-response curves in Figure 1 , the NO generators diethylenetriamine NO adduct (DETA-NO), S-nitroso-Nacetylpenicillamine (SNAP), and sodium nitroprusside (SNP) completely prevent the death of PC12 cells at 24 hr after serum deprivation and do so at concentrations of -100,50, and 300 PM, respectively.
We next examined the length of time that NO donors were able to maintain cell viability in this paradigm. Figure 2A shows that NO promotes complete survival for 1 d but that afterward cell viability begins to decline so that 50-80% are supported by 2 d and, in the cases of DETA-NO and SNP, 30-40% at 3 d. Readdition of the NO donors at 12 or 24 hr intervals did not prolong cell survival in the absence of trophic support (data not shown). Cells were cultured f& 24 hr in serum-free medium with or without 100 uM DETA-NO or 100 tiM SNAP. then NGF was added as indicated. Cells maintained continuously in strum-free medium containing NGF are shown for reference. Cell numbers were determined at 1 and 3 d after serum-deprivation times and are expressed relative to the number initially plated (day 0). All data arc the mean i SEM of three samples.
Thus, in contrast to NGF, these agents block cell death for only a limited period of treatment. To confirm the viability of the cells maintained by the NO generators, cultures were prepared in serumfree medium with 100 PM DETA-NO or 100 PM SNAP and then 1 d later NGF was added to selected dishes. The cultures were scored for viability 1 and 3 d after serum deprivation. Under these conditions, the cells that had been treated for 1 d with DETA-NO and SNAP and then exposed to NGF were still alive at day 3, whereas those cultures that did not receive NGF 1 d after serum deprivation had almost no surviving cells (Fig. 2B ). These observations confirm that the cells judged to be maintained by NO generators were indeed alive and not irreversibly committed to death.
Several lines of evidence indicate that it is the NO generated by the donors that is responsible for the promotion of survival in our experiments. First, the addition of hemoglobin to the serum-free culture medium blocks the protective effects of DETA-NO, presumably by scavenging NO and preventing its action on intracellular targets. Second, in contrast to SNAP, the control thiol penicillamine, added at the same concentration does not prevent the death of serum-deprived PC12 cells (data not shown). In addition, the ability of the NO generators to promote survival is transcription-independent, because it is not blocked by addition of 10 PM actinomycin D (data not shown).
NO generators suppress the death of neuronal PC12 cells and primary sympathetic neurons after removal of NGF We next tested whether NO generators affect the death of PC12 cells that were neuronally differentiated by long-term treatment with NGF in serum-free medium, and then deprived of the factor. Serum-deprived neuronal PC12 cells, like sympathetic neurons, die after NGF withdrawal, with -5O-60% of the cells dead after 2 d. Addition of 100 FM DETA-NO or 100 pM SNAP to cultures of ncuronal PC12 cells after withdrawal of NGF resulted in near complete survival for up to 2 d, and 60-75% survival at 3 d. In contrast, only 30% of untreated cells remained viable at the latter time (Fig. 3A) . The gradual decrease in the number of cells maintained by the drugs was not attributable to toxic effects because the cells remain fully viable when NGF was present in combination (data not shown). In the absence of NGF, the NO generators do not promote neurite regeneration, nor do they prevent this process in the presence of NGF (data not shown).
To extend our observations to a neuronal model, we examined the effects of the NO generators on NGF-deprived sympathetic neurons. In this paradigm, sympathetic neurons from 2-d-old rats were cultured in the presence of NGF for 3 d and then deprived of the factor. Under these conditions, -75% of the neurons die within 48 hr and virtually all die by 4-5 d. Addition of DETA-NO or SNAP to cultures of sympathetic neurons immediately after NGF withdrawal significantly delayed their death (Fig. 3B) . After 2 d of deprivation, -65-75% of the NO generator-treated neurons were viable compared with <35% of their untreated counterparts. Enhanced survival was still evident at 4 d of deprivation with 25% of the neurons still present. Readdition of the NO generators did not prolong survival nor did the presence of the generators interfere with the ability of NGF to prevent death. Figure 8 shows that the neurons rescued by the NO generators retain a typical phase bright appearance and that there is a degree of maintenance of their neurite network.
Discordance between the capacities of NO generators to block cell death and cell proliferation Previous studies have shown that GliS blockers rescue PC12 cells and sympathetic neurons as well as other cell types from death. Given the ability of NO-generating compounds to block PC12 cell proliferation (Peunova and Enikolopov, 1995) , we tested whether this might correlate with their ability to protect neuronal cells from apoptotic death after the loss of trophic support. Each of the three NO generators inhibited [3H]thymidine incorporation by dividing PC12 cells in a concentration-dependent manner (Fig. 4) . vided complete protection from death at 100, 50, and 300 PM rcspectivcly, whereas at these same concentrations thymidine incorporation was blocked by only -50%. This finding contrasts with our own previous studies that showed a tight quantitative correlation between the abilities of GUS inhibitors to block cell cycle progression and to promote survival of PC12 cells in serumfree conditions . These data suggest that the ability of NO to promote serum-free survival is unlikely to be related to its cytostatic effects. Also, in contrast to Gl/S blockers, pretreatment with the NO generators before serum deprivation was not necessary to promote complete PC12 cell survival at 24 hr. Additionally, the cytostatic effects of the NO donors on proliferating PC12 cells did not diminish even after 4 d, again consistent with a disjunction between promotion of survival and inhibition of proliferation (data not shown).
Inhibition
of guanylate cyclase blocks the ability of NO to promote survival of PC12 cells and primary sympathetic neurons after withdrawal of trophic support Because elevation of intracellular cGMP is one major mechanism by which effects of NO are mediated, we examined whether inhibition of guanylate cyclase would affect NO-mediated survival. The compound LY 83583 has been shown to inhibit soluble guanylate cyclase (Mulsch et al., 1988) and to block the NOmediated increase in intracellular cGMP in a variety of cell types (Laychock et al., 1991) , and has been shown to inhibit NOmediated actions in PC12 cells (Desole et al., 1993) . When 0.5 PM LY 83583 was added to serum-deprived PC12 cell cultures concurrent with addition of the NO donors DETA-NO, SNAP, or SNP, the survival-promoting effect of the agents was blocked (Fig. 5A) . In this paradigm LY 83583 does not block the action of NGF on serum-free survival. Similar results were obtained with 10 PM methylene blue, another inhibitor of guanylate cyclase (Gruetter et al., 1981) (data not shown).
LY 83583 also blocked the ability of SNAP to promote survival of primary sympathetic neurons that had been deprived of NGF. LY 83583 had no effects on survival in the absence of NGF nor did it block the ability of NGF to maintain survival (Fig. 5B ). These data suggest that the survival promoting effects of NO are mediated through activation of guanylate cyclase. In contrast, it appears that the action of NGF in promotion of survival is not mediated by cGMP.
Inhibition of cGMP-specific phosphodiesterase enhances the survival effects of the NO donors To test further whether cGMP mediates the neuroprotective effect of NO, we examined the consequences on cell survival of blocking cGMP phosphodiesterase. Dipyridamole is a relatively selective inhibitor of cGMP-specific phosphodiesterase (Beavo and Reifsnyder, 1990) . We first tested dipyridamole for its effects on serum-deprived PC12 cells. When administered alone, 10 pM dipyridamole has a negligible effect on survival in this paradigm. However, when added in combination with the NO generators DETA-NO, SNAP, or SNP, dipyridamole causes a consistent shift in the potency of these agents by about threefold (Fig. 6A-C) . Dipyridamole also prolongs the time that the NO generators support survival of serum-deprived PC12 cells so that with the drug, there was complete survival for 2 d after serum withdrawal (Fig. 60) . However, by the third day there was no significant difference in viability between cells treated with the NO generators plus dipyridamole and those cells treated with the generators alone, although survival in both groups was significantly greater than the untreated control cultures (data not shown). Inhibition of cGMP phosphodiesterase with 100 FM Zaprinast similarly enhanced the survival-promoting effects of the NO donors on serum-deprived PC12 cells (data not shown).
Dipyridamole also prolonged the survival of sympathetic neurons deprived of NGF and maintained with the NO generator SNAP. Addition of 10 FM dipyridamole alone had negligible effects on survival in this paradigm, but extended the length of survival of the SNAP-treated cultures by -1 d compared with SNAP alone (Fig. 6E ).
Permeant
cGMP analogs promote survival of trophic factor-deprived PC12 cells and primary sympathetic neurons We next tested whether cGMP had direct effects on neuronal cell survival by adding the permeant cGMP analogs S-bromo-cGMP (8-Br-cGMP) or chlorphenylthio-cGMP (CPT-cGMP) to cultures of serum-deprived PC12 cells. Both analogs promote serum-free survival in a concentration-dependent manner (Fig. 7A) . CPTcGMP prevents cell death completely at a concentration of 1 mM (EC,, -0.3 mM>, whereas X-Br-cGMP completely protects at 10 mM (EC,, -3 mM). Five days after removal of serum, 60% of PC12 cells were still maintained by 10 mM 8-Br-cGMP, whereas none of the untreated control cells survived. In contrast, addition of 10 mM 8-bromoguanosine 5'-monophosphate had no effect on survival of serum-deprived PC12 cells; therefore, survival appears unlikely to be attributable to a nonspecific action of the nucleotide derivative. It is also unlikely that the cGMP analogs promote survival by blocking cell proliferation, because treatment of dividing PC12 cells with 10 mM &Br-cGMP resulted in only a 30% inhibition of ['Hlthymidine incorporation compared with untreated control cultures.
Addition of the permeant cGMP analogs to cultures of sympathetic neurons immediately after NGF withdrawal rescued them from death (Fig. 7B) . After 2 d of deprivation, -90% of the 8-Br-cGMP-treated neurons and 70% of the CPT-cGMP-treated neurons were alive compared with ~20% of their untreated counterparts. 8-Br-cGMP had good long-term effects on survival as -50% of the neurons remained viable 7 d after removal of NGF whereas CPT-cGMP had shorter-lived effects on survival. Such cultures treated with these analogs maintained their neurite network in the absence of NGF in contrast to the dying, untreated controls (Fig. 8) . The NOS inhibitor N-nitro-L-arginine methyl ester (L-NAME) does not block NGF-promoted survival of serum-deprived PC12 cells NGF has been reported to induce NO synthase in PC12 cells and the induction of NOS and subsequent generation of NO has been causally linked to the cessation of proliferation and neuronal differentiation initiated by NGF (Peunova and Enikolopov, 1995) . We tested whether inhibition of NOS would prevent the NGF-promoted survival of serum-deprived PC12 cells. When added immediately after serum withdrawal at concentrations up to 20 mM, the NOS inhibitor L-NAME failed to block NGF-promoted survival of PC12 cells (data not shown). Even after 5 d in the presence of high concentrations of L-NAME, NGF maintained complete survival of PC12 cells, indicating that the action of NGF on survival is not mediated by NO. L-NAME by itself had no effect on survival in this paradigm. In addition, L-NAME (10 mM) did not block NGF-promoted survival of neuronal PC12 cells in serum-free medium or of primary sympathetic neurons (data not shown).
DISCUSSION
In the present study we show that neuronal cell death initiated by withdrawal of trophic support can be significantly delayed by NO generators. Our findings suggest that the survival-promoting effect of NO is mediated by elevation of intracellular cGMP, implicating either or both of these messenger molecules as regulators of survival or apoptosis. Furthermore, our data indicate that the mechanism by which NGF promotes neuronal survival is unlikely to involve the production of NO or activation of soluble guanylate cyclase. We and others have hypothesized that trophic factors such as NGF promote survival either by guiding proliferating neuroblasts through the cell cycle, by causing dividing neuroblasts to differentiate and withdraw from the cell cycle, or by causing postmitotic neurons to remain out of the cycle Rubin et al., 1993; Ferrari and Greene, 1994; Ferrari et al., 1995; Farinelli and Greene, 1996) . We have provided support for this model by showing that blockade of the cell cycle by molecular or pharmacological means is sufficient to prevent death of PC12 cells and sympathetic neurons after withdrawal of trophic support (Ferrari and Greene, 1994; Ferrari et al., 1995; Yan et al., 1995; Farinelli and Greene, 1996; Park et al., in press) . Because it has been demonstrated that NGF treatment of PC12 cells leads to induction of a constitutively active form of NOS and that the production or application of NO initiates cessation of proliferation by these cells (Peunova and Enikolopov, 1995) , it was reasonable to test whether the cytoprotective effects of NO were causally related to inhibition of cellular proliferation. When NO generators were tested for their ability to promote PC12 cell survival in serum-free conditions and to inhibit PC12 DNA synthesis, it became evident that the dose-response curves for these two processes did not strictly correlate (Figs. 1, 4 ). This discordance is not evident with N-acetylcysteine Gl/S blockers and permeant CAMP analogs and inhibitors of cyclin dependent kinases (Park et al., in press) , in that each blocked cell death and DNA synthesis with similar potencies.
Because inhibition of cell proliferation was not sufficient to explain the cytoprotective effects of NO, we looked toward one of the main targets of its action, guanylate cyclase. Past studies have demonstrated that NO generators elevate cGMP levels in PC12 cells (Whalin et al., 1991) . Inhibition of guanylate cyclase with LY 83583 and methylene blue was sufficient to block the protective actions of the NO generators in our models. In addition, it was possible to enhance and prolong the effects of NO generators by cotreating with the cGMP phosphodiesterase inhibitor dipyridamole. These data together with the cytoprotection afforded by the permeant cGMP analogs strongly suggest that the effect of NO on survival in our paradigm is mediated by activation of guanylate cyclase and generation of cGMP. Our findings are consistent with those demonstrating that cGMP mediates the effect of NO in preventing B-cell death (Genaro et al., 1995) and in preventing the death of cytokine-deprived eosinophils (Beauvais et al., 1995) . In addition, a study by Weill and Greene (1984) showed that naturally occurring death of chick motor neurons could be prevented by dibutyryl cGMP. Moreover, Barger et al. (1995) demonstrated that secreted forms of the /3-amyloid precursor protein Figure 8 . Phase-contrast micrographs of cultured primary sympathetic neurons maintained for 3 d after withdrawal of NGF and addition of (A) no additives, (B) 100 rig/ml NGF, (C) 100 pM DETA-NO, (0) 300 PM SNAP, and (I!?) 10 mM 8-Br-cGMP. Magnification, 375X.
protected cultured hippocampal neurons against glucose deprivation and glutamate toxicity by increasing cGMP levels. Taken together, these data strongly suggest that cGMP may be a regulator of neuronal survival.
Our effects of NO on neuronal survival are short-lived and cannot be prolonged by readdition of NO generators, suggesting that the protective response is somehow downregulated. The observations that inhibition of cGMP phosphodiesterase prolongs the protective action of NO and that &Br-cGMP maintains survival longer than does NO indicate that the downregulation occurs at the level of guanylate cyclase. This idea is supported by studies of the circulatory system that show that guanylate cyclase is sensitive to the continued presence of NO in that this enzyme can be upregulated by removal of NO (Moncada et al., 1991) and downregulated by extended exposure to NO donors (Axelsson and Andersson, 1983; Waldman et al., 1986) .
One of the known targets of cGMP action is the cyclic nucleotide phosphodiesterase family, which, depending on the isoform, can be either stimulated or inhibited by the cyclic nucleotide (Sonnenburg and Beavo, 1994) . This raises the possibility that NO may indirectly affect the intracellular level of CAMP through cGMP-mediated inhibition of phosphodiesterase. A related possibility was that cGMP derivatives we used might similarly raise intracellular CAMP or even mimic the action of the latter. Previous studies have demonstrated that elevation of intracellular CAMP or addition of a permeant CAMP analog result in long-term maintenance of survival after trophic factor withdrawal from PC12 cells and sympathetic neurons (Rydel and Greene, 1988; Rukenstein et al., 1991) . However, we have observed a close quantitative correlation between the ability of a CAMP analog to block PC12 cell proliferation and to prevent cell death . In contrast, 8-Br-cGMP inhibits ["Hlthymidine incorporation by just 30% at 10 mM, the concentration required to completely block cell death in our experiments. A similar absence of correlation between survival and DNA synthesis was observed with NO generators. Moreover, Whalin et al. (1991) reported that elevation of cGMP in PC12 cells activates phosphodiesterase II and that this in turn increases the rate of CAMP degradation in the cells. Thus, present observations do not favor the likelihood that NO or cGMP promote survival by a CAMPdependent mechanism.
Downregulation of copper/zinc superoxide dismutase (SODl) in PC12 cells using an antisense oligonucleotide leads to their rapid apoptotic death (Troy and Shelanski, 1994) . In this model, NO generators expedite cell death while inhibitors of NOS abolish cell death, suggesting that formation of peroxynitrite is necessary for this process (Troy et al., 1996) . In the models of trophic factor deprivation-induced death presented here, NO generators promote survival and inhibition of NOS has no effect. It is conceivable that NO becomes cytotoxic only under conditions of increased superoxide. Because NO has been reported to be a potential mediator of NMDA neurotoxicity after ischemia (Nowicki et al., 1991; Dawson et al., 1993) it appears likely that the oxidative state of the target cell can determine whether NO is cytoprotective or cytotoxic.
It has been known for some time that SOD prolongs the effect of exogenous NO, presumably by reducing the level of superoxide (Moncada et al., 1986; Ignarro et al., 1987) and thus diminishing its reaction with NO to form peroxynitrite.
It has also been reported that SOD itself is capable of catalyzing the reversible conversion of nitroxyl anion to NO, a reaction that would serve to prolong the action of NO (Murphy and Sies, 1991) . With regard to the finding by Greenlund et al. (1995) who reported that microinjection of copper/zinc SOD or SOD expression vector delayed the death of sympathetic neurons deprived of NGF, it is conceivable that this treatment results in an increase in intracellular levels of NO by the mechanisms mentioned above, and consequently leads to cGMP accumulation and prolonged survival.
In summary, we have shown that NO may play a role in promoting neuronal survival. In our models of trophic factor withdrawal, this effect appears to be mediated by cGMP. Our findings thus predict that signals in addition to NO that result in elevation or maintenance of intracellular cGMP may contribute to cell survival. In this light, it is of interest that natriuretic peptides increase cGMP in neuronal cells (Toki et al., 1992) and that guanylate cyclase can be activated by protein kinase C (Louis et al., 1993) activators of which can block apoptosis in both neuronal and non-neuronal cells (Rajotte et al., 1992; Batistatou and Greene, 1993; Lucas et al., 1994 Lucas et al., ,1995 . Carbon monoxide, which is produced physiologically by the action of heme oxygenase, also activates guanylate cyclase, and interestingly these two enzymes colocalize in the brain (Verma et al., 1993) . It is thus conceivable that in addition to conventional trophic factors, NO and other signaling molecules that elevate intracellular cGMP may serve to prevent neuronal apoptosis in development as well as in the mature organism. It also follows that manipulation of intracellular cGMP represents a potentially useful means to prevent death of neurons and other cells caused by disease or injury.
